Dr James P Smith, OD | |
1 Va Ctr, Togus Vamc Eye Clinic, Augusta, ME 04330-6719 | |
(207) 623-8411 | |
Not Available |
Full Name | Dr James P Smith |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1 Va Ctr, Augusta, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013932110 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 2938 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James P Smith, OD 56 Chapel St # 3, Augusta, ME 04330-7324 Ph: (207) 215-7797 | Dr James P Smith, OD 1 Va Ctr, Togus Vamc Eye Clinic, Augusta, ME 04330-6719 Ph: (207) 623-8411 |
News Archive
Repetitive transcranial magnetic stimulation uses a non-invasive and relatively painless tool to stimulate the human brain in vivo using very strong, pulsed magnetic fields. It is also used to explore and elucidate neocortical functions and treat neuropsychiatric disorders.
Following an inspection blitz by the Food and Drug Administration (FDA) on companies which handle a variety of human material from deceased donors, no serious problems have apparently been unearthed.
Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.
Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
› Verified 2 days ago
Smart Vision, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 255 Western Ave, Augusta, ME 04330 Phone: 207-622-5800 Fax: 207-621-2790 | |
Benjamin I Graham, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Hannah Michaella Wood, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Va Center, Surgical Service 112 E, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Stephanie Lynn Arnio, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Advanced Vision Care Of Maine Optometrist Medicare: Medicare Enrolled Practice Location: 254 Western Ave, Augusta, ME 04330 Phone: 207-622-3015 Fax: 207-621-7716 | |
Dr. Leah D Grotton, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 58 State St, Augusta, ME 04330 Phone: 207-623-5099 Fax: 207-623-7124 |